Search
Descriptor English: Brimonidine Tartrate
Descriptor Spanish: Tartrato de Brimonidina
Descriptor tartrato de brimonidina
Scope note: Derivado de la quinoxalina y AGONISTA DE RECEPTOR ADRENÉRGICO ALFA-2 que se utiliza para controlar la PRESIÓN INTRAOCULAR asociada con el GLAUCOMA DE ÁNGULO ABIERTO e HIPERTENSIÓN OCULAR.
Descriptor Portuguese: Tartarato de Brimonidina
Descriptor French: Tartrate de brimonidine
Entry term(s): 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
5-bromo-6-(imidazolidinylideneamino)quinoxaline
5-bromo-6-(imidazolin-2-ylamino)quinoxaline
AGN 190342
AGN-190342
AGN190342
Alphagan
Alphagan P
Brimonidine
Brimonidine Purite
Brimonidine Tartrate (1:1)
Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer
Brimonidine Tartrate, (R-(R*,R*))-Isomer
Bromoxidine
Mirvaso
Ratio Brimonidine
Ratio-Brimonidine
Sanrosa
UK 14,304
UK 14,304 18
UK 14,304-18
UK 14,30418
UK 14,308
UK 14304
UK 14308
UK-14,304-18
UK-14,308
UK-14304
UK14,30418
UK14,308
UK14304
Tree number(s): D03.633.100.857.070
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068438
Scope note: A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Adrenergic alpha-2 Receptor Agonists
Registry Number: 4S9CL2DY2H
CAS Type 1 Name: 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
Public MeSH Note: 2016; BRIMONIDINE TARTRATE was indexed under QUINOXALINES 1980-2015, and under IMIDAZOLES 1978-1980
History Note: 2016 (1978)
DeCS ID: 55937
Unique ID: D000068438
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2018/05/21
Brimonidine Tartrate - Preferred
Concept UI M0065049
Scope note A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Preferred term Brimonidine Tartrate
Entry term(s) 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer - Narrower
Concept UI M0312903
Preferred term Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer
Brimonidine Purite - Narrower
Concept UI M0517501
Preferred term Brimonidine Purite
AGN 190342 - Narrower
Concept UI M0065040
Preferred term AGN 190342
Entry term(s) AGN-190342
AGN190342
Sanrosa - Narrower
Concept UI M000603526
Preferred term Sanrosa
Alphagan - Narrower
Concept UI M000603394
Preferred term Alphagan
Brimonidine - Broader
Concept UI M000603395
Preferred term Brimonidine
Entry term(s) 5-bromo-6-(imidazolidinylideneamino)quinoxaline
5-bromo-6-(imidazolin-2-ylamino)quinoxaline
Bromoxidine
Alphagan P - Narrower
Concept UI M000638382
Preferred term Alphagan P
UK 14,304 - Narrower
Concept UI M0065042
Preferred term UK 14,304
Entry term(s) UK 14304
UK-14304
UK14304
Ratio-Brimonidine - Narrower
Concept UI M000603399
Preferred term Ratio-Brimonidine
Entry term(s) Ratio Brimonidine
UK 14,304-18 - Narrower
Concept UI M0065043
Preferred term UK 14,304-18
Entry term(s) UK 14,304 18
UK 14,30418
UK-14,304-18
UK14,30418
UK 14308 - Narrower
Concept UI M0065045
Preferred term UK 14308
Entry term(s) UK 14,308
UK-14,308
UK14,308
Brimonidine Tartrate, (R-(R*,R*))-Isomer - Narrower
Concept UI M0312901
Preferred term Brimonidine Tartrate, (R-(R*,R*))-Isomer
Brimonidine Tartrate (1:1) - Narrower
Concept UI M0312902
Preferred term Brimonidine Tartrate (1:1)
Mirvaso - Narrower
Concept UI M000603397
Preferred term Mirvaso



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey